These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6918437)

  • 1. Parkinsonism: forgotten considerations in medical treatment and nursing care.
    Garrett E
    J Neurosurg Nurs; 1982 Feb; 14(1):13-8. PubMed ID: 6918437
    [No Abstract]   [Full Text] [Related]  

  • 2. [Risks in the treatment of parkinsonism with l-dopa and a dopa decarboxylase inhibitor].
    Jörg J
    Med Welt; 1979 Nov; 30(46):1740-2. PubMed ID: 537499
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug therapy of parkinsonism.
    Bianchine JR
    N Engl J Med; 1976 Oct; 295(15):814-8. PubMed ID: 958277
    [No Abstract]   [Full Text] [Related]  

  • 4. Appraisal of long-term levodopa treatment of parkinsonism with special reference to therapy limiting factors.
    Presthus J; Holmsen R
    Acta Neurol Scand; 1974; 50(6):774-90. PubMed ID: 4440452
    [No Abstract]   [Full Text] [Related]  

  • 5. [Risks of modern therapy for parkinsonism, and their consequences (author's transl)].
    Jörg J; Kleine D
    Nervenarzt; 1979 Jan; 50(1):33-42. PubMed ID: 424033
    [No Abstract]   [Full Text] [Related]  

  • 6. Individualization of drug therapy for the parkinsonian patient.
    JAMA; 1975 Sep; 233(11):1198-201. PubMed ID: 240043
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison between EEG-finding and clinical picture in patients with Parkinsonism under L-dopa].
    Bengesser G
    Wien Med Wochenschr; 1975 Feb; 125(7-8):120-1. PubMed ID: 1146347
    [No Abstract]   [Full Text] [Related]  

  • 8. Levodopa for the treatment of Parkinson's disease.
    Lewitt PA
    N Engl J Med; 2008 Dec; 359(23):2468-76. PubMed ID: 19052127
    [No Abstract]   [Full Text] [Related]  

  • 9. Nosological concept of juvenile parkinsonism with reference to the dopa-responsive syndrome.
    Yokochi M
    Adv Neurol; 1993; 60():548-52. PubMed ID: 8420189
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects and side effects of levodopa in parkinsonism-results of a collaborative study. (1) Therapeutic responses in relation to the etiology and clinical types].
    Ito K
    Rinsho Shinkeigaku; 1976 Dec; 16(12):869-70. PubMed ID: 1035527
    [No Abstract]   [Full Text] [Related]  

  • 11. Exogenous levodopa is not toxic to elderly subjects with non-parkinsonian movement disorders: further clinical evidence.
    Hagenah J; Klein C; Sieberer M; Vieregge P
    J Neural Transm (Vienna); 1999; 106(3-4):301-7. PubMed ID: 10392538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute psychotic status after sudden interruption of treatment of Parkinsonism with levodopa].
    Ledić P; Sepcić J; Antoncić N
    Neurologija; 1977; 25(1-2):95-7. PubMed ID: 616879
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of parkinsonism.
    Godwin-Austen R
    Practitioner; 1975 Oct; 215(1288):445-51. PubMed ID: 1202468
    [No Abstract]   [Full Text] [Related]  

  • 14. Rationale for early use of levodopa in parkinsonism.
    Pincus JH
    Lancet; 1986 Mar; 1(8481):612-3. PubMed ID: 2869319
    [No Abstract]   [Full Text] [Related]  

  • 15. Levodopa in the treatment of Parkinson's disease.
    Lloyd KG
    Prim Care; 1977 Sep; 4(3):541-60. PubMed ID: 264229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe ataxic polyneuropathy associated with chronic levodopa use in Parkinson's disease.
    Kimber T; Blumbergs P; Thompson P
    Parkinsonism Relat Disord; 2013 Sep; 19(9):847-9. PubMed ID: 23746939
    [No Abstract]   [Full Text] [Related]  

  • 17. CSF biopterin levels and clinical features of patients with juvenile parkinsonism.
    Furukawa Y; Nishi K; Kondo T; Mizuno Y; Narabayashi H
    Adv Neurol; 1993; 60():562-7. PubMed ID: 8420192
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects and side effects of levodopa in parkinsonism - results of a collaborative study. (3) Side effects of levodopa].
    Mizuno Y
    Rinsho Shinkeigaku; 1976 Dec; 16(12):874-6. PubMed ID: 1035529
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects and side effects of levodopa in parkinsonism- results of a collaborative study].
    Ando K
    Rinsho Shinkeigaku; 1976 Dec; 16(12):867-8. PubMed ID: 1035526
    [No Abstract]   [Full Text] [Related]  

  • 20. Exaggerated response to levodopa. A case of "contaminated parkinsonism".
    Hinterbuchner LP; Hinterbuchner C
    J Am Med Womens Assoc (1972); 1974 Dec; 29(12):552-4. PubMed ID: 4374472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.